NCT01706497View on ClinicalTrials.gov

Predictive Value of the FORE-SIGHT™ Monitor for Hemodynamic Deterioration

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Pediatric Congenital Heart Surgery
Interventions
DEVICE

Cerebral tissue oxygen saturation monitoring, blinded

Trial Locations (1)

3000

Department of intensive care medicine, university hospitals Leuven, Leuven

Sponsors

Collaborators (1)

CAS Medical Systems, Inc.
All Listed Sponsors
collaborator

CAS Medical Systems, Inc.

INDUSTRY

lead

KU Leuven

OTHER